Colon Cancer
Advanced colon cancer care with individualized treatment plans including surgery, chemotherapy, and targeted therapies.
Overview
Colorectal cancer is the third most common cancer in the United States, but outcomes have improved significantly with modern screening, surgical techniques, and systemic therapies. Our team manages all stages from early-stage resectable disease through advanced metastatic colorectal cancer.
Molecular profiling — including MSI, RAS, BRAF, and HER2 testing — guides our treatment decisions, ensuring each patient receives the most effective targeted therapy or immunotherapy available.
Symptoms & Warning Signs
- Change in bowel habits (diarrhea or constipation)
- Blood in the stool or rectal bleeding
- Persistent abdominal discomfort or cramping
- Unexplained weight loss
- Fatigue and weakness
- Feeling that the bowel does not empty completely
Diagnosis & Evaluation
Imaging
CT scan, PET/CT, and MRI of pelvis
Colonoscopy & Biopsy
Tissue sampling with histopathology
Molecular Testing
MSI/MMR, KRAS, NRAS, BRAF, HER2
CEA Monitoring
Tumor marker tracking
Treatment Options
Frequently Asked Questions
When should I start colon cancer screening?
Current guidelines recommend screening colonoscopy beginning at age 45. If you have a family history of colorectal cancer or polyps, screening may need to start earlier.
What does MSI-high mean for my treatment?
MSI-high (microsatellite instability-high) tumors respond exceptionally well to immunotherapy, sometimes achieving durable remissions even in advanced disease.
